Ditchcarbon
  • Contact
  1. Organizations
  2. Karius, Inc.
Public Profile
Research Services
US
updated 2 months ago

Karius, Inc. Sustainability Profile

Company website

Karius, Inc., a pioneering force in the field of infectious disease diagnostics, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of advanced genomic technologies for the detection of pathogens. Karius is renowned for its innovative Karius Test, which utilises next-generation sequencing to identify a wide range of infectious agents from a simple blood sample, setting it apart in the diagnostics industry. With a strong operational presence across the US and expanding internationally, Karius is committed to improving patient outcomes through precise and timely diagnostics. The company has achieved significant milestones, including partnerships with leading healthcare institutions, solidifying its position as a trusted provider in the realm of infectious disease management.

DitchCarbon Score

How does Karius, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Karius, Inc.'s score of 23 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Let us know if this data was useful to you

Karius, Inc.'s reported carbon emissions

Karius, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Karius, Inc. may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. As the company navigates the evolving landscape of corporate sustainability, it is essential for Karius, Inc. to establish clear climate goals and reduction strategies to align with industry standards and expectations. Engaging with frameworks such as the Science Based Targets initiative (SBTi) could provide a structured approach to setting meaningful emissions reduction targets in the future.

How Carbon Intensive is Karius, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Karius, Inc.'s primary industry is Research Services, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Karius, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Karius, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Karius, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Karius, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Karius, Inc.'s Emissions with Industry Peers

PathAI, Inc.

US
•
Computer and related services (72)
Updated 7 days ago

Illumina

US
•
Research and development services (73)
Updated 2 days ago

OpGen, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Noscendo GmbH

DE
•
Research and development services (73)
Updated 18 days ago

GRAIL, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy